Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (18)

« Back to Publications

0594 Drug-testing in patient-derived renal cell carcinoma organoids reveals pathways of vulnerability and resistance

Steven M. et al, (2026), European Urology, 89, S1 - S2

Circulating tumour cells as a window into lethality in prostate cancer.

Abusamra SM. et al, (2026), Nat Rev Urol

Integrating multi-omic datasets investigating stress response biology decodes prostate cancer dynamic disease progression and places IRE1 activity at the epicentre of acquired treatment resistance

Doultsinos D. et al, (2026), CANCER RESEARCH, 86

IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer

Doultsinos D. et al, (2025)

Quality of English- and Spanish-language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities.

Abusamra SM. et al, (2025), BJUI Compass, 6

Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing.

Abusamra SM. et al, (2025), Urol Pract, 12, 63 - 72

Integrating multiparametric MRI with spatial transcriptomics to identify "Radio-Spatial Genomic" features of prostate cancer using artificial intelligence

Anbarasan T. et al, (2025), CANCER RESEARCH, 85

Mapping clonal heterogeneity and stromal dynamics in prostate cancer

Figiel S. et al, (2025), CANCER RESEARCH, 85

PATIENT-DERIVED RENAL CELL CANCER ORGANOIDS AS A MODEL TO ASSESS THERAPEUTIC TARGETS AND TREATMENT RESISTANCE MECHANISMS

Daniel AT. et al, (2025), UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 43

DISPARITIES IN GENETIC TESTING FOR PROSTATE CANCER IN SPANISH-PREFERRING PATIENTS

Loeb S. et al, (2025), JOURNAL OF UROLOGY, 213

DETECTION OF GERMLINE VARIANTS IN PATIENTS WITH LOCALIZED AND METASTATIC PROSTATE CANCER THROUGH GUIDELINE-BASED TESTING

Solorzano MA. et al, (2025), JOURNAL OF UROLOGY, 213

Circulating tumour cell isolation and enrichment for investigation of prostate cancer metastasis

Abusamra S. et al, (2024), The Journal of Liquid Biopsy, 5, 100251 - 100251

The integrated on-chip isolation and detection of circulating tumour cells.

Abusamra SM. et al, (2024), Sens Diagn, 3, 562 - 584

SPATIAL TRANSCRIPTOMIC CLONAL DECONVOLUTION IDENTIFIES THE 'LETHAL CLONE' IN PROSTATE CANCER AS DEFINED BY ABILITY TO METASTASIZE TO LYMPH NODES

Yin W. et al, (2024), JOURNAL OF UROLOGY, 211, E182 - E182

EXPLORING STROMAL DYNAMICS IN PROSTATE CANCER: INSIGHTS FROM SPATIAL TRANSCRIPTOMIC ANALYSES

Figiel S. et al, (2024), JOURNAL OF UROLOGY, 211, E181 - E181

Load More